Successful Use of Cyclophosphamide and Prednisone for Initial Treatment of Pemphigus Vulgaris

Archives of Dermatology

Volumn 114, Issue 6, 1978, Pages 889-894

  Fellner, Michael J ^a   Katz, James M ^a   Mccabe, Jonathan B ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPEN N; AMCILL S; AMPICILLIN; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DICLOXACILLIN; ERYTHROMYCIN; PREDNISONE; UNCLASSIFIED DRUG;

DRUG THERAPY; PEMPHIGUS VULGARIS; THERAPY;

ADULT; AGED; AZATHIOPRINE; CASE REPORT; CHILD; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FEMALE; HUMAN; MALE; METHOTREXATE; MIDDLE AGE; PEMPHIGUS; PREDNISONE;

EID: 0018239837     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archderm.1978.01640180023005     Document Type: Article

References (23)

1. 1. Lever WF, Goldberg HS: Treatment of pemphigus vulgaris with methotrexate. Arch Dermatol 100:70-78, 1969.
2. 2. Peck SM, Osserman KE: Studies in bullous diseases: Treatment of pemphigus vulgaris with methotrexate, two patients. J Mt Sinai Hospital 36:71-76, 1969.
3. 3. Wolff K, Schreiner B: Immunosuppressant therapie bei pemphigus vulgaris. Arch Klin Exp Dermatol 235:63-77, 1969.
4. 4. Krakowski A, Covo J, Rozanski Z: Pemphigus vulgaris. Arch Dermatol 100:117, 1969.
5. 5. Ebringer A, McKay IR: Pemphigus vulgaris successfully treated with cyclophosphamide. Ann Intern Med 71:125-127, 1969.
6. 6. Beutner EH, Jordan RE: Demonstration of skin antibodies in sera of pemphigus vulgaris patients by indirect immunofluorescence staining. Proc Soc Exp Biol Med 117:505-510, 1964.
7. 7. Jablonska S, Chorzelski T, Blaszczyk M: Immunosuppressants in the treatment of pemphigus. Br J Dermatol 83:315-323, 1970.
8. 8. Burton JH, Greaves MW, Marks JM, et al: Azathioprine in pemphigus vulgaris. Br Med J 3:84-86, 1970.
9. 9. Burton JH, Greaves MW: Azathioprine for pemphigus and pemphigoid: A four-year follow-up. Br J Dermatol 91:103-109, 1974.
10. 10. Van Dyck TJA, van Velde JH: Treatment of pemphigus and pemphigoid with azathioprine. Dermatologica 147:179-185, 1973.
11. 11. McKelvey EM, Hasegawa J: Cyclophosphamide and pemphigus vulgaris. Arch Dermatol 103:198-200, 1971.
12. 12. Krain LS, Landau JW, Newcomer VD: Cyclophosphamide in the treatment of pemphigus vulgaris and bullous pemphigoid. Arch Dermatol 106:657-661, 1972.
13. 13. Medved A, Maxwell I: Intermittent cyclophosphamide in pemphigus vulgaris and bullous pemphigoid. Can Med Assoc J 111:245-250, 1974.
14. 14. Glickman FS, Silvers SH: Pemphigus vulgaris treated with cyclophosphamide. Arch Dermatol 107:467-468, 1973.
15. 15. Pasricha JS, Sood VD, Minocha Y: Treatment of pemphigus with cyclophosphamide. Br J Dermatol 93:573-576, 1975.
16. 16. Lever WF: Methotrexate and prednisone in pemphigus vulgaris: Therapeutic results obtained in 36 patients between 1961 and 1970. Arch Dermatol 106:491-497, 1972.
17. 17. Roenigk HH, Deodhor S: Pemphigus treatment with azathioprine: Clinical and immunological correlation. Arch Dermatol 107:353-357, 1973.
18. 18. Grieco MH: Immunosuppressive drug therapy. Drug Therapy 1:9, 1971.
19. 19. Pecker JL: Cytotoxic drugs in treatment of nonmalignant diseases. Ann Intern Med 76:619-642, 1972.
20. 20. Wall RL, Clausen KP: Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 293:271-273, 1975.
21. 21. Gershwin ME, Goetzl EJ, Steinberg AD: Cyclophosphamide use in practice. Ann Intern Med 80:531-537, 1974.
22. 22. Krain LS, Terasaki PJ, Newcomer VD, et al: Increased frequency of HL-A10 in pemphigus vulgaris. Arch Dermatol 108:803-805, 1973.
23. 23. Lever WF, Schaumburg-Lever G: Immunosuppressants and prednisone in pemphigus vulgaris. Arch Dermatol 113:1236-1241, 1977.